Cargando…
Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
Currently available prognostic tools appear unable to adequately predict recurrence and progression in non muscle-invasive bladder carcinomas. We aimed to assess the prognostic value of immunohistochemical evaluation of the cell cycle markers p53, p16 and pRb. Paraffin blocks were obtained from 78 c...
Autores principales: | Hitchings, A W, Kumar, M, Jordan, S, Nargund, V, Martin, J, Berney, D M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409830/ https://www.ncbi.nlm.nih.gov/pubmed/15226775 http://dx.doi.org/10.1038/sj.bjc.6601954 |
Ejemplares similares
-
Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation
por: Southern, S A, et al.
Publicado: (2004) -
Quantitative Analysis of Tumor-Associated Mast Cells in Recurrent and Non-recurrent Urothelial Bladder Cancer in Stage pTa and pT1
por: Popov, Hristo, et al.
Publicado: (2021) -
p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016) -
Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours
por: Yoshida, T, et al.
Publicado: (2004) -
Antitumor mechanisms when pRb and p53 are genetically inactivated
por: Zhu, Liang, et al.
Publicado: (2014)